Mixed Connective Tissue Disease
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Mixed Connective Tissue Disease

What is the definition of Mixed Connective Tissue Disease?
Mixed connective tissue disease (MCTD) is a rare autoimmune disorder that is characterized by features commonly seen in three different connective tissue disorders: systemic lupus erythematosus, scleroderma, and polymyositis. Some affected people may also have symptoms of rheumatoid arthritis. Signs and symptoms vary but may include Raynaud's phenomenon; arthritis; heart, lung and skin abnormalities; kidney disease; muscle weakness, and dysfunction of the esophagus. The cause of MCTD is currently unknown.
What are the alternative names for Mixed Connective Tissue Disease?
  • Mixed connective tissue disease
  • MCTD
  • Sharp syndrome
Who are the top Mixed Connective Tissue Disease Local Doctors?
Advanced in Mixed Connective Tissue Disease
Rheumatology
Advanced in Mixed Connective Tissue Disease
Rheumatology
Referral required

OSF Medical Group - Rheumatology

1800 North Knoxville Avenue, 
Peoria, IL 
Languages Spoken:
English, Hindi, Sindhi, Urdu
Accepting New Patients
Offers Telehealth

Imran Umer is a Rheumatologist practicing medicine in Peoria, Illinois. Dr. Umer is rated as an Advanced provider by MediFind in the treatment of Mixed Connective Tissue Disease. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Rhizomelic Pseudopolyarthritis, Polymyalgia Rheumatica, Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), and Tissue Biopsy. Dr. Umer is board certified in American Board Of Internal Medicine. Dr. Umer is currently accepting new patients.

Elite in Mixed Connective Tissue Disease
Elite in Mixed Connective Tissue Disease
Referral may be required
Warsaw, MZ, PL 

Agnieszka Paradowska-Gorycka practices practicing medicine in Warsaw, Poland. Ms. Paradowska-Gorycka is rated as an Elite expert by MediFind in the treatment of Mixed Connective Tissue Disease. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Mixed Connective Tissue Disease, Rheumatoid Arthritis (RA), Arthritis, and Systemic Lupus Erythematosus (SLE).

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Mixed Connective Tissue Disease
Elite in Mixed Connective Tissue Disease
Referral may be required
Oslo, NO 

Ragnar Gunnarsson practices practicing medicine in Oslo, Norway. Mr. Gunnarsson is rated as an Elite expert by MediFind in the treatment of Mixed Connective Tissue Disease. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Mixed Connective Tissue Disease, Antisynthetase Syndrome, Myositis, and Vasculitis.

What are the latest Mixed Connective Tissue Disease Clinical Trials?
Transforming Health Habits: Evaluating an Online Wellness Program for Individuals With Rheumatological Conditions and Mood Disorders

Summary: The goal of this project is to critically evaluate the effectiveness of an online health program designed to improve diet and self-care in patients with rheumatological conditions, including rheumatoid arthritis (RA), Sjogren's syndrome (SS), systemic lupus erythematosus (SLE), mixed connective tissue disease (MCTD), psoriatic arthritis (PsA), anxiety disorders, depressive disorders and moderate d...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Prevention of Recurrence of Herpes Simplex in Patients With Autoimmune Rheumatic Diseases

Summary: The goal of this randomized, double-blind, placebo-controlled clinical trial is to evaluate the effectiveness and safety of oral suppressive therapy with acyclovir in preventing herpes simplex virus (HSV) reactivation in patients with autoimmune rheumatic diseases (ARDs) who have a history of recurrent HS episodes. The main questions this study aims to answer are: Does continuous oral acyclovir re...

Who are the sources who wrote this article ?

Published Date: May 13, 2022
Published By: Genetic and Rare Diseases Informnation Center